$BOTY
LINGERIE FIGHTING CHAMPIONSHIPS, INC.

2024 Q3 Form 10-Q Financial Statement

#000164033424001114 Filed on July 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q1 2023 Q4
Revenue $23.53K $45.03K $28.96K
YoY Change -27.49% 78.68% -17.19%
Cost Of Revenue $12.51K $34.20K $17.67K
YoY Change 19.7% 37.64% 92.69%
Gross Profit $11.02K $10.83K $11.29K
YoY Change -49.9% 2992.86% -56.24%
Gross Profit Margin 46.84% 24.04% 38.98%
Selling, General & Admin $15.66K $49.42K $68.08K
YoY Change -83.02% -18.58% 4.79%
% of Gross Profit 142.09% 456.54% 603.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $169.1K $49.42K $68.08K
YoY Change 83.38% -18.58% 4.77%
Operating Profit -$158.1K -$38.60K -$56.79K
YoY Change 125.15% -36.05% 44.95%
Interest Expense $109.8K $82.59K $489.3K
YoY Change 66.64% -801.73% -34.22%
% of Operating Profit
Other Income/Expense, Net -$612.0K -$2.191M
YoY Change 10.25% 18512.12%
Pretax Income -$770.1K -$2.230M $432.5K
YoY Change 23.15% 2991.36% -38.62%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$770.1K -$2.230M $432.5K
YoY Change 23.15% 2991.36% -38.62%
Net Earnings / Revenue -3272.61% -4952.03% 1493.51%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 3.955B shares 3.712B shares
Diluted Shares Outstanding 14.76B shares 14.24B shares

Balance Sheet

Concept 2024 Q3 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.350K $5.300K
YoY Change 190.12% -47.05%
Cash & Equivalents $12.84K $2.346K $5.295K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $12.84K $2.346K $5.295K
YoY Change 307.07% 189.63% -47.1%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.00 $5.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $12.84K $2.346K $5.295K
Total Long-Term Assets $4.00 $5.00
Total Assets $2.350K $5.300K
YoY Change 190.12% -47.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $688.3K $652.6K
YoY Change 13.59% 12.57%
Accrued Expenses $729.0K $669.0K
YoY Change 46.65% 51.06%
Deferred Revenue
YoY Change
Short-Term Debt $1.067M $1.044M
YoY Change 10.29% 12.89%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.687M $6.412M $4.204M
YoY Change 13.01% 28.81% -14.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.687M $6.412M $4.204M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $6.412M $4.204M
YoY Change 28.81% -14.45%
SHAREHOLDERS EQUITY
Retained Earnings -$10.91M -$11.53M -$9.303M
YoY Change 8.4% -6.44%
Common Stock $4.505M $3.955M $3.897M
YoY Change 21.37% 4.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.674M -$6.409M -$4.199M
YoY Change
Total Liabilities & Shareholders Equity $12.84K $2.346K $5.295K
YoY Change 307.07% 189.63% -47.1%

Cashflow Statement

Concept 2024 Q3 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$770.1K -$2.230M $432.5K
YoY Change 23.15% 2991.36% -38.62%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$2.949K -$56.86K
YoY Change -91.6% 169.61%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 59.00K
YoY Change -100.0% 218.57%
NET CHANGE
Cash From Operating Activities -$2.949K -56.86K
Cash From Investing Activities $0.00
Cash From Financing Activities $0.00 59.00K
Net Change In Cash -$2.949K 2.140K
YoY Change -67.95% -183.27%
FREE CASH FLOW
Cash From Operating Activities -$2.949K -$56.86K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Revenues
Revenues
25195 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
24846 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11773 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
7647 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
60702 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-60353 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
71583 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
900 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
2346 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
18141 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
728957 usd
CY2024Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
726610 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3927717 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1838806 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6411553 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4204402 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3896930 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1206572 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
10825 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
349 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18104 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-6409207 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10495 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
669015 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
703958 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9302609 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4199107 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
5295 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001407704
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
51 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
51 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3954844036 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3896928536 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-55498
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
LINGERIE FIGHTING CHAMPIONSHIPS, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8009362
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
6955 North Durango Drive
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1115-129
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89149
CY2024Q1 dei City Area Code
CityAreaCode
702
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
505-0743
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3954844036 shares
CY2024Q1 boty Related Party Transaction Amounts Of Transaction Accounts Payable
RelatedPartyTransactionAmountsOfTransactionAccountsPayable
670128 usd
CY2023Q4 boty Related Party Transaction Amounts Of Transaction Accounts Payable
RelatedPartyTransactionAmountsOfTransactionAccountsPayable
642128 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
340000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
340000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
41364 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
64016 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3954844036 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3896928536 shares
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2346 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5295 usd
CY2024Q1 us-gaap Revenues
Revenues
45028 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
34203 usd
CY2024Q1 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
12598 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
49420 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-38595 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
82594 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2108611 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
59810 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2191205 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11773 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-72126 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2229800 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-72126 usd
CY2024Q1 boty Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
CY2023Q1 boty Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q1 boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
3914748690 shares
CY2023Q1 boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
3711714036 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14238160521 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11262253844 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4199107 usd
CY2024Q1 boty Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
19700 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2229800 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4572242 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-72126 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4644368 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2229800 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-72126 usd
CY2024Q1 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
2108611 usd
CY2023Q1 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-59810 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
22652 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
17389 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7646 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
251 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
28000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
25000 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
59942 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
54194 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2949 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35102 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2024Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2023Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25900 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2949 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9202 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5295 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10009 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2346 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
807 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 boty Common Stock Issued For Exercise Of Warrants
CommonStockIssuedForExerciseOfWarrants
19700 usd
CY2023Q1 boty Common Stock Issued For Exercise Of Warrants
CommonStockIssuedForExerciseOfWarrants
0 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lingerie Fighting Championships, Inc. (the “Company”) is a Nevada corporation incorporated on November 29, 2006 under the name Sparking Events, Inc. The Company’s corporate name was changed to Xodtec Group USA, Inc. in June 2009, Xodtec LED, Inc. in May 2010, Cala Energy Corp. in September 2013 and Lingerie Fighting Championships, Inc. on April 1, 2015.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company focuses on developing, producing, promoting, and distributing entertainment through live entertainment events, digital home videos, broadcast television networks, video on demand, and digital media channels in the United States. It offers wrestling and mixed martial arts fights featuring women under the LFC brand name.</p>
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company continually evaluates its estimates and judgments. The Company bases its estimates and judgments on historical experience and other factors that it believes to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known, even for estimates and judgments that are not deemed critical.</p>
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2346 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5295 usd
CY2024Q1 us-gaap Revenues
Revenues
45028 usd
CY2023Q1 us-gaap Revenues
Revenues
25195 usd
CY2023Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
40468 usd
CY2024Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
577183 usd
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10323411831 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7550539808 shares
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
3927717 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1838806 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
530405 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5637133523 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0001
CY2023 boty Number Of Shares Granted
NumberOfSharesGranted
184883994 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.0005
CY2023 boty Exercised
Exercised
-227308705 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.0001
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5594708812 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0002
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 boty Exercised
Exercised
-71078114 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.0001
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5523630698 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0002
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
57915500 shares
CY2024Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
71078114 shares
CY2024Q1 boty Expected Term
ExpectedTerm
P1Y9M25D
CY2023Q1 boty Expected Term
ExpectedTerm
P2Y8M1D
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2634867 usd
CY2023 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
29111 usd
CY2023 boty Reduction Of Derivative Liabilities From Exercise Of Warrants
ReductionOfDerivativeLiabilitiesFromExerciseOfWarrants
-64683 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
920000 usd
CY2024Q1 boty Closing Market Price
ClosingMarketPrice
0.0003
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5523630698 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5594708812 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1638482 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1093440 shares
CY2024Q1 us-gaap Notes Payable
NotesPayable
340000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
340000 usd
CY2021Q1 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
150000000 shares
CY2021Q1 boty Warrants Price Per Share
WarrantsPricePerShare
0.002
CY2021Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
35000 usd
CY2021Q1 boty Warrants Derivative Amount
WarrantsDerivativeAmount
265000 usd
CY2021Q1 boty Debt Instrument Aggregate Discount
DebtInstrumentAggregateDiscount
300000 usd
CY2021Q4 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
50000000 shares
CY2021Q4 boty Warrants Price Per Share
WarrantsPricePerShare
0.0008
CY2021Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
9000 usd
CY2021Q4 boty Warrants Derivative Amount
WarrantsDerivativeAmount
31000 usd
CY2021Q4 boty Debt Instrument Aggregate Discount
DebtInstrumentAggregateDiscount
40000 usd
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
726610 usd
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
703958 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
29306 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
13891 usd
CY2024Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
46778 usd
CY2023 boty Addition Of New Derivative Liabilities Upon Issuance Of Warrants As Debt Discount
AdditionOfNewDerivativeLiabilitiesUponIssuanceOfWarrantsAsDebtDiscount
59000 usd
CY2023 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
101123 usd
CY2023 boty Gain Loss On Change In Fair Value Of The Derivative Liability
GainLossOnChangeInFairValueOfTheDerivativeLiability
-920612 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1838806 usd
CY2024Q1 boty Reduction Of Derivative Liabilities From Exercise Of Warrants
ReductionOfDerivativeLiabilitiesFromExerciseOfWarrants
-19700 usd
CY2024Q1 boty Gain Loss On Change In Fair Value Of The Derivative Liability
GainLossOnChangeInFairValueOfTheDerivativeLiability
2108611 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
3927717 usd
CY2024Q1 boty Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants
GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants
2108611 usd
CY2023Q1 boty Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants
GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants
-59810 usd
CY2024Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
2108611 usd
CY2023Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-59810 usd
CY2024Q1 boty Related Party Transaction Amounts Of Transaction Accounts Payable
RelatedPartyTransactionAmountsOfTransactionAccountsPayable
670128 usd
CY2023Q4 boty Related Party Transaction Amounts Of Transaction Accounts Payable
RelatedPartyTransactionAmountsOfTransactionAccountsPayable
642128 usd

Files In Submission

Name View Source Status
0001640334-24-001114-index-headers.html Edgar Link pending
0001640334-24-001114-index.html Edgar Link pending
0001640334-24-001114.txt Edgar Link pending
0001640334-24-001114-xbrl.zip Edgar Link pending
boty-20240331.xsd Edgar Link pending
boty_10q.htm Edgar Link pending
boty_ex311.htm Edgar Link pending
boty_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
boty-20240331_cal.xml Edgar Link unprocessable
boty-20240331_def.xml Edgar Link unprocessable
boty-20240331_lab.xml Edgar Link unprocessable
boty-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
boty_10q_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending